Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Harvard Business School
Merck
McKinsey
McKesson

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NORVIR

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Norvir

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002447 A Study to Compare Two Anti-HIV Drug Combinations Completed Hoffmann-La Roche Phase 3 1999-10-01 The purpose of this study is to compare 2 anti-HIV drug combinations.
NCT00005017 Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment Unknown status Glaxo Wellcome Phase 4 1969-12-31 The purpose of this study is to see how effective and safe it is to give 1 of the 3 following treatments to patients who may not have received anti-HIV treatment: 1) lamivudine (3TC)/abacavir (ABC)/stavudine (d4T); 2) 3TC/ABC/efavirenz (EFV); or 3) 3TC/ABC/amprenavir (APV)/ritonavir (RTV).
NCT00145561 The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-Infected Pregnant Women. Completed Hoffmann-La Roche Phase 1/Phase 2 2005-08-01 Pharmacokinetic study of Saquinavir and Ritonavir in HIV-infected pregnant women
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Norvir

Condition Name

Condition Name for Norvir
Intervention Trials
HIV Infections 19
HIV Infection 6
HIV 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Norvir
Intervention Trials
HIV Infections 27
Hepatitis 6
Hepatitis C 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Norvir

Trials by Country

Trials by Country for Norvir
Location Trials
United States 46
United Kingdom 10
Argentina 7
Mexico 7
Germany 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Norvir
Location Trials
California 6
New York 5
Colorado 3
North Carolina 3
Florida 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Norvir

Clinical Trial Phase

Clinical Trial Phase for Norvir
Clinical Trial Phase Trials
Phase 4 13
Phase 3 9
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Norvir
Clinical Trial Phase Trials
Completed 28
Unknown status 5
Recruiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Norvir

Sponsor Name

Sponsor Name for Norvir
Sponsor Trials
Bristol-Myers Squibb 6
Merck Sharp & Dohme Corp. 4
R-Pharm 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Norvir
Sponsor Trials
Other 46
Industry 32
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Mallinckrodt
Merck
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.